Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

May 3, 2019

Primary Completion Date

January 3, 2025

Study Completion Date

January 3, 2025

Conditions
IronDiabetesNonalcoholic Fatty Liver
Interventions
PROCEDURE

Blood Donation

Participants in the TREATMENT GROUP will have a Unit of blood (two cups, the same amount you would donate at the Red Cross) drawn. This involves having a needle inserted into a vein in your arm. Prior to taking the blood, staff will measure blood count to be sure participants are not anemic, and blood pressure to be sure there is no dehydration. During or after donation, participants will be given a sports drink to replace the fluid loss. Participants in the CONTROL GROUP will not donate blood, but will have a needle inserted into a vein in your arm. Neither group will not know to which they have been assigned, all will have a sleep mask (like a blindfold, covering the eyes, held on with an elastic band) placed so they will not know whether blood was actually removed.

PROCEDURE

Sham Blood Donation

Participants will have a needle inserted their arm, however, no blood will be drawn.

Trial Locations (2)

27157

Wake Forest University Health Sciences, Winston-Salem

27599-2100

University of North Carolina at Chapel Hill (UNC), Chapel Hill

All Listed Sponsors
collaborator

University of North Carolina, Chapel Hill

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT03696797 - Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter